Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer

被引：35

作者：

Bommareddy, Praveen K. ^{[1
]}

Peters, Cole ^{[2
,3
,4
]}

Saha, Dipongkor ^{[2
,3
]}

Rabkin, Samuel D. ^{[2
,3
]}

Kaufman, Howard L. ^{[1
]}

机构：

[1] Rutgers Canc Inst New Jersey, Dept Surg, New Brunswick, NJ 08903 USA

[2] Massachusetts Gen Hosp, Dept Neurosurg, Mol Neurosurg Lab, Boston, MA 02114 USA

[3] Harvard Med Sch, Boston, MA 02114 USA

[4] Harvard Med Sch, Program Virol, Boston, MA 02115 USA

来源：

ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2 | 2018年 / 2卷

关键词：

oncolytic viruses; immunotherapy; immuno-virotherapy; T-VEC; melanoma; HSV; NF-KAPPA-B; ADAPTIVE IMMUNE-RESPONSES; DENDRITIC CELLS; PROTEIN-SYNTHESIS; TALIMOGENE LAHERPAREPVEC; INTERFERON-PRODUCTION; GAMMA(1)34.5 PROTEIN; ANTITUMOR EFFICACY; MALIGNANT GLIOMAS; SIGNALING PATHWAY;

D O I：

10.1146/annurev-cancerbio-030617-050254

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Oncolytic viruses are native or modified viruses that directly kill tumor cells but spare normal tissue and promote host antitumor immunity. Recently, an oncolytic herpes simplex virus (oHSV) type 1-encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrated significant clinical benefit in a randomized phase III clinical trial for patients with advanced melanoma, leading to regulatory approval in 2015. In this review, we provide a general characterization of herpes simplex viruses and discuss methods for vector modification, which can help limit viral pathogenicity and immunogenicity while promoting antitumor immunogenicity. We also provide insight into general strategies for using oHSV agents in tumor immunotherapy regimens for the treatment of cancer and briefly review some of the currently emerging preclinical and clinical data that support an important role for such agents in the treatment of cancer.

引用

页码：155 / 173

页数：19

共 173 条

[21] Retargeting Strategies for Oncolytic Herpes Simplex Viruses [J].

Campadelli-Fiume, Gabriella ;

Petrovic, Biljana ;

Leoni, Valerio ;

Gianni, Tatiana ;

Avitabile, Elisa ;

Casiraghi, Costanza ;

Gatta, Valentina .

VIRUSES-BASEL, 2016, 8 (03)

[22] Viral and cellular contributions to herpes simplex virus entry into the cell [J].

Campadelli-Fiume, Gabriella ;

Menotti, Laura ;

Avitabile, Elisa ;

Gianni, Tatiana .

CURRENT OPINION IN VIROLOGY, 2012, 2 (01) :28-36

[23]

Cassady KA, 1998, J VIROL, V72, P7005

[24] Second-site mutation outside of the US10-12 domain of Δγ134.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially. restores neurovirulence [J].

Cassady, KA ;

Gross, M ;

Gillespie, GY ;

Roizman, B .

JOURNAL OF VIROLOGY, 2002, 76 (03) :942-949

[25] Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model [J].

Cheema, Tooba A. ;

Wakimoto, Hiroaki ;

Fecci, Peter E. ;

Ning, Jianfang ;

Kuroda, Toshihiko ;

Jeyaretna, Deva S. ;

Martuza, Robert L. ;

Rabkin, Samuel D. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (29) :12006-12011

[26] Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts [J].

Cheema, Tooba A. ;

Kanai, Ryuichi ;

Kim, Geon Woo ;

Wakimoto, Hiroaki ;

Passer, Brent ;

Rabkin, Samuel D. ;

Martuza, Robert L. .

CLINICAL CANCER RESEARCH, 2011, 17 (23) :7383-7393

[27] A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases [J].

Chen, Xilin ;

Han, Jianfeng ;

Chu, Jianhong ;

Zhang, Lingling ;

Zhang, Jianying ;

Chen, Charlie ;

Chen, Luxi ;

Wang, Youwei ;

Wang, Hongwei ;

Yi, Long ;

Elder, J. Bradley ;

Wang, Qi-En ;

He, Xiaoming ;

Kaur, Balveen ;

Chiocca, E. Antonio ;

Yu, Jianhua .

ONCOTARGET, 2016, 7 (19) :27764-27777

[28] Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase PERK and mediates eIF-2α dephosphorylation by the γ134.5 protein [J].

Cheng, GF ;

Feng, ZD ;

Bin, H .

JOURNAL OF VIROLOGY, 2005, 79 (03) :1379-1388

[29] Innate and Adaptive Immune Responses to Herpes Simplex Virus [J].

Chew, Tracy ;

Taylor, Kathryne E. ;

Mossman, Karen L. .

VIRUSES-BASEL, 2009, 1 (03) :979-1002

[30] MAPPING OF HERPES-SIMPLEX VIRUS-1 NEUROVIRULENCE TO GAMMA-134.5, A GENE NONESSENTIAL FOR GROWTH IN CULTURE [J].

CHOU, J ;

KERN, ER ;

WHITLEY, RJ ;

ROIZMAN, B .

SCIENCE, 1990, 250 (4985) :1262-1266

← 1 2 3 4 5 6 7 8 9 10 →